This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Shuji Fukunaga Hidetoshi Akashi Shigeaki Aoyagi Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tayama, E. Articles by Aoyagi, S. Search for Related Content PubMed PubMed Citation Articles by Tayama, E. Articles by Aoyagi, S. Related Collections Cardiac - pharmacology Cardiac - physiology Cardiac - other

Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension

Department of Surgery, Kurume University Hospital, 67 Asahi-machi, Kurume City, 830-0011, Japan

*Corresponding author. Tel.: +81-942-35-3311 ext 3542; fax: +81-942-35-8967.

E-mail address: eiki{at}med.kurume-u.ac.jp (E. Tayama).

Low systemic vascular resistance (SVR) hypotension concomitant with pulmonary hypertension (PH) is difficult to manage postoperatively because they are often catecholamine-resistant. So, we applied arginine vasopressin (AVP), which is a potent vasoconstrictor in a specific condition, for post-cardiotomy refractory low SVR hypotension concomitant with PH. We treated nine cases of postoperative refractory vasodilatory hypotension concomitant with PH even after conventional treatment that included nitric oxide inhalation and/or intraaortic balloon pump. AVP was administrated with 0.050.1 U/min intravenously. After AVP administration, the mean systemic arterial pressure increased from 47.3±9.5 to 76.5±12.2 mmHg (P<0.01) and SVR increased from 488.1±92.7 to 1188±87 dynes·s·cm^–5 (P<0.01). Fortunately, even though the cardiac index decreased, it remained in a normal range. Alteration in the PVR was not significant, but the Pp/Ps became somewhat lower (0.66±0.2 to 0.47±0.16, P<0.01). AVP increased the urine output and improved oxygenation. AVP improved systemic circulation (increased systemic blood pressure with maintaining cardiac output) without deterioration of pulmonary hypertension. AVP is an ideal drug for treating refractory low SVR hypotension concomitant with PH. But its indication must be limited.

Key Words: Arginine vasopressin; Low systemic vascular resistance; Pulmonary hypertension; Post-cardiac surgery management

This article has been cited by other articles:

				A. Noto, S. Lentini, A. Versaci, M. Giardina, D. C. Risitano, R. Messina, and A. David A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery Interactive CardioVascular and Thoracic Surgery, October 1, 2009; 9(4): 588 - 592. [Abstract] [Full Text] [PDF]